Starton Therapeutics Overview
- Year Founded
-
2017
- Status
-
IPO Registration
- Employees
-
7
- Latest Deal Type
-
IPO
- (Announced)
- Latest Deal Amount
-
$30M
- Investors
-
4
Starton Therapeutics General Information
Description
Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.
Contact Information
Website
www.startontx.comCorporate Office
- 215 College Road
- Suite 300
- Paramus, NJ 07652
- United States
Corporate Office
- 215 College Road
- Suite 300
- Paramus, NJ 07652
- United States
Starton Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. IPO | 11-Dec-2025 | $30M | Announced | Generating Revenue/Not Profitable | ||
| 8. Reverse Merger | 03-Nov-2023 | Cancelled | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC | 11-Oct-2023 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC | 01-Jun-2022 | Completed | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC | 16-Feb-2022 | Completed | Clinical Trials - Phase 2 | |||
| 4. Early Stage VC | 19-Nov-2021 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC | 26-May-2021 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series B) | 13-Jan-2020 | $2.04M | $15.7M | Completed | Clinical Trials - Phase 2 | |
| 1. Early Stage VC (Series A) | 18-Jul-2018 | $13.7M | $13.7M | Completed | Clinical Trials - Phase 2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Starton Therapeutics Comparisons
Industry
Financing
Details
Starton Therapeutics Competitors (3)
One of Starton Therapeutics’s 3 competitors is Heron Therapeutics, a Formerly VC-backed company based in Cary, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Heron Therapeutics | Formerly VC-backed | Cary, NC | ||||
| Kyowa Kirin International | Formerly PE-Backed | Galashiels, United Kingdom | ||||
| Helsinn Healthcare | Corporation | Lugano, Switzerland |
Starton Therapeutics Patents
Starton Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260224497-A1 | Controlled release delivery of low water solubility compounds via oral administration | Pending | 31-Jan-2025 | ||
| WO-2026164922-A1 | Controlled release delivery of low water solubility compounds via oral administration | Pending | 31-Jan-2025 | ||
| WO-2026151833-A1 | Non-aqueous stable solutions for subcutaneous drug delivery | Pending | 09-Jan-2025 | ||
| AU-2025206255-A1 | Solid state active pharmaceutical compositions for transdermal drug delivery | Pending | 05-Jan-2024 | ||
| EP-4836802-A1 | Solid state active pharmaceutical compositions for transdermal drug delivery | Pending | 05-Jan-2024 | A61K9/7061 |
Starton Therapeutics Signals
Starton Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endeavor Capital Management | Venture Capital | Minority | ||
| Jolt Health | Corporation | Minority | ||
| Accent Capital | Venture Capital | Minority | ||
| MBX Capital | Venture Capital | Minority |
Starton Therapeutics FAQs
-
When was Starton Therapeutics founded?
Starton Therapeutics was founded in 2017.
-
Where is Starton Therapeutics headquartered?
Starton Therapeutics is headquartered in Paramus, NJ.
-
What is the size of Starton Therapeutics?
Starton Therapeutics has 7 total employees.
-
What industry is Starton Therapeutics in?
Starton Therapeutics’s primary industry is Drug Discovery.
-
Is Starton Therapeutics a private or public company?
Starton Therapeutics is a Private company.
-
What is the current valuation of Starton Therapeutics?
The current valuation of Starton Therapeutics is .
-
What is Starton Therapeutics’s current revenue?
The current revenue for Starton Therapeutics is .
-
How much funding has Starton Therapeutics raised over time?
Starton Therapeutics has raised $57M.
-
Who are Starton Therapeutics’s investors?
Endeavor Capital Management, Jolt Health, Accent Capital, and MBX Capital have invested in Starton Therapeutics.
-
Who are Starton Therapeutics’s competitors?
Heron Therapeutics, Kyowa Kirin International, and Helsinn Healthcare are competitors of Starton Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process